Clinical Trial: A Trial of Centanafadine Efficacy and Safety in Adults With Attention-deficit/Hyperactivity Disorder and Comorbid Anxiety

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06973577) titled 'A Trial of Centanafadine Efficacy and Safety in Adults With Attention-deficit/Hyperactivity Disorder and Comorbid Anxiety' on May 07.

Brief Summary: Phase 3b, Randomized, Double-blind, 8-week, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Centanafadine Once Daily Extended-release Capsules for the Treatment of Adults with Attention-deficit/Hyperactivity Disorder and Comorbid Anxiety

Study Start Date: March 26

Study Type: INTERVENTIONAL

Condition: ADHD Anxiety, Generalized Anxiety, Social Anxiety Disorder

Intervention: DRUG: Centanafadine

Centanafadine QD XR fixed dose 328.8mg

Recruitment Status: RECRUITING

S...